Abstract
A patient with idiopathic marrow hypoplasia associated with short stature and other anomalies (Fanconi's anaemia) is described: treatment with human growth hormone for one year did not accelerate his growth rate or significantly affect his anaemia: androgen treatment considerably improved both features. Endocrine studies suggest that though he had poor and insufficient production of endogenous growth hormone to insulin-induced hypoglycaemia, the major defect in this syndrome is determined more at the end-organ than at the pituitary or gonadal level.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Perkins J., Timson J., Emery A. E. Clinical and chromosome studies in Fanconi's aplastic anaemia. J Med Genet. 1969 Mar;6(1):28–33. doi: 10.1136/jmg.6.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steel C. M., Butterworth S. T., Keay A. J. Endocrine studies in a case of congenital (erythroid) hypoplastic anaemia. Acta Haematol. 1972;47(2):109–117. doi: 10.1159/000208502. [DOI] [PubMed] [Google Scholar]
- Swift M. R., Hirschhorn K. Fanconi's anemia. Inherited susceptibility to chromosome breakage in various tissues. Ann Intern Med. 1966 Sep;65(3):496–503. doi: 10.7326/0003-4819-65-3-496. [DOI] [PubMed] [Google Scholar]
- Zachmann M., Illig R., Prader A. Fanconi's anemia with isolated growth hormone deficiency. J Pediatr. 1972 Jan;80(1):159–160. doi: 10.1016/s0022-3476(72)80485-2. [DOI] [PubMed] [Google Scholar]